{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:43:00Z","timestamp":1777081380455,"version":"3.51.4"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Non-Hodgkin lymphoma affecting the brain, eyes, and cerebrospinal fluid without systemic spread is known as primary central nervous system lymphoma (PCNSL). While intracerebroventricular PCNSL is commonly found in the lateral ventricles and the third and fourth ventricles, the occurrence of PCNSL originating from the septum pellucidum is extremely rare.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Concerns:<\/jats:title>\n            <jats:p>Two patients presented with recent memory loss and high cranial pressure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Magnetic resonance imaging revealed a clear enhancing lesion in the septum pellucidum region. Pathological examination confirmed that both cases were primary large B-cell lymphoma GCB (germinal center B-cell-like) subtypes located in an \u201cimmune-privileged\u201d area.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Both patients underwent total tumor resection, and the procedures were successfully completed without surgical complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Over a 1-year period, treatment included four cycles of high-dose methotrexate combined with temozolomide. During the follow-up period (19\u201323 months), no recurrence of the lymphoma was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In cases of PCNSL in the septum pellucidum, it is crucial to consider it as a potential differential diagnosis for intraventricular tumors. Surgical interventions should focus on maximizing tumor resection while ensuring the protection of critical structures like the fornix and peripheral neural components. The role of surgery compared to biopsy, as well as the long-term complications, necessitates extended follow-up. Additionally, an individualized treatment approach, considering factors such as age, Karnofsky performance score, and organ function assessment, can lead to positive outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035954","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:27:16Z","timestamp":1701163636000},"page":"e35954","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8764-6547","authenticated-orcid":false,"given":"Dawei","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Hospital of Jilin University, Changchun, Jilin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuzhe","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuechao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma.","volume":"140","author":"Schaff","year":"2022","journal-title":"Blood"},{"key":"R2-20250504","first-page":"1476","article-title":"Central nervous system lymphomas.","volume":"26","author":"Grommes","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases.","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.","volume":"16","author":"Hoang-Xuan","year":"2015","journal-title":"Lancet Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2021.03.01","article-title":"Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version).","volume":"33","author":"Zhu","year":"2021","journal-title":"Chin J Cancer Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.tranon.2018.11.011","article-title":"Primary central nervous system lymphoma: molecular pathogenesis and advances in treatment.","volume":"12","author":"Cai","year":"2019","journal-title":"Transl Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/cncr.30965","article-title":"Diagnosis and management of primary central nervous system lymphoma.","volume":"123","author":"Han","year":"2017","journal-title":"Cancer"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/ijri.IJRI_23_18","article-title":"Myriad of MR imaging phenotypes of primary central nervous system lymphoma in a cohort of immunocompetent Indian patient population.","volume":"28","author":"Neelakantan","year":"2018","journal-title":"Indian J Radiol Imaging"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/1097-0142(19940815)74:4<1383::AID-CNCR2820740432>3.0.CO;2-1","article-title":"Pathology with clinical correlations of primary central nervous system non-Hodgkin\u2019s lymphoma The Massachusetts General Hospital experience 1958-1989.","volume":"74","author":"Miller","year":"1994","journal-title":"Cancer"},{"issue":"Suppl 1","key":"R10-20250504","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10428190802311441","article-title":"Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment.","volume":"49","author":"Rubenstein","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00428-019-02698-3","article-title":"Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.","volume":"476","author":"King","year":"2020","journal-title":"Virchows Arch"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ajh.23551","article-title":"The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin\u2019s lymphoma.","volume":"88","author":"O\u2019Neill","year":"2013","journal-title":"Am J Hematol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/neuonc\/nos207","article-title":"Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center.","volume":"14","author":"Welch","year":"2012","journal-title":"Neuro Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3892\/ijo.2021.5180","article-title":"Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).","volume":"58","author":"Liu","year":"2021","journal-title":"Int J Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/annonc\/mdv076","article-title":"First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.","volume":"26","author":"Kasenda","year":"2015","journal-title":"Ann Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-017-2435-7","article-title":"Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.","volume":"133","author":"Houillier","year":"2017","journal-title":"J Neurooncol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/leu.2016.334","article-title":"High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).","volume":"31","author":"Fritsch","year":"2017","journal-title":"Leukemia"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1200\/JCO.2003.11.036","article-title":"Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.","volume":"21","author":"Hoang-Xuan","year":"2003","journal-title":"J Clin Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/annonc\/mdn628","article-title":"High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.","volume":"20","author":"Illerhaus","year":"2009","journal-title":"Ann Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e318266fcb2","article-title":"Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.","volume":"79","author":"Roth","year":"2012","journal-title":"Neurology"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ajh.23812","article-title":"A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma The GOELAMS LCP 99 trial.","volume":"89","author":"Olivier","year":"2014","journal-title":"Am J Hematol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s003300101037","article-title":"Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.","volume":"12","author":"Coulon","year":"2002","journal-title":"Eur Radiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-004-3390-7","article-title":"Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.","volume":"72","author":"K\u00fcker","year":"2005","journal-title":"J Neurooncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1754-9485.2012.02345.x","article-title":"Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.","volume":"56","author":"Yap","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2214\/AJR.14.14092","article-title":"Imaging of nervous system involvement in hematologic malignancies: what radiologists need to know.","volume":"205","author":"Keraliya","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"923206","DOI":"10.3389\/fneur.2022.923206","article-title":"Case report: Ventricular primary central nervous system lymphoma with partial hypointensity on diffusion-weighted imaging.","volume":"13","author":"Li","year":"2022","journal-title":"Front Neurol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"920505","DOI":"10.3389\/fneur.2022.920505","article-title":"Clinical features, diagnosis, and treatment of primary intraventricular lymphoma: insights from a monocentric case series.","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Neurol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"593.e9","DOI":"10.1016\/j.wneu.2012.07.026","article-title":"Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.","volume":"79","author":"Cheatle","year":"2013","journal-title":"World Neurosurg"},{"key":"R29-20250504","first-page":"989","article-title":"The septum pellucidum: normal and abnormal.","volume":"10","author":"Sarwar","year":"1989","journal-title":"AJNR Am J Neuroradiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/B:NEON.0000014541.87329.3b","article-title":"Central neurocytoma: a review.","volume":"66","author":"Schmidt","year":"2004","journal-title":"J Neurooncol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.clineuro.2012.09.010","article-title":"A case of cavernous angioma in the septum pellucidum.","volume":"115","author":"Katoh","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNN.0000000000000048","article-title":"Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.","volume":"28","author":"Deutsch","year":"2015","journal-title":"Cogn Behav Neurol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1752-1947-5-213","article-title":"Primary central nervous system lymphoma presenting as a pure third ventricular lesion: a case report.","volume":"5","author":"Sasani","year":"2011","journal-title":"J Med Case Rep"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clineuro.2011.10.020","article-title":"Multifocal lateral and fourth ventricular B-cell primary CNS lymphoma.","volume":"114","author":"Brar","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3174\/ajnr.A1750","article-title":"Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.","volume":"31","author":"Barajas","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0032-1312862","article-title":"Glioblastomas vs lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI).","volume":"184","author":"Peters","year":"2012","journal-title":"Rofo"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"CNS46","DOI":"10.2217\/cns-2019-0016","article-title":"Utility of flouro-deoxy-glucose positron emission tomography\/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma.","volume":"8","author":"Gupta","year":"2019","journal-title":"CNS Oncol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"28897","DOI":"10.18632\/oncotarget.25622","article-title":"Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.","volume":"9","author":"Chihara","year":"2018","journal-title":"Oncotarget"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/neuonc\/not319","article-title":"Different spatial distribution between germinal center B and non-germinal center B primary central nervous system lymphoma revealed by magnetic resonance group analysis.","volume":"16","author":"Kinoshita","year":"2014","journal-title":"Neuro Oncol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jnen\/nlz125","article-title":"Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.","volume":"79","author":"B\u00f6d\u00f6r","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/neuonc\/nov197","article-title":"Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma Analysis of 7 cases and systematic review of the literature.","volume":"18","author":"Izquierdo","year":"2016","journal-title":"Neuro Oncol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1212\/01.wnl.0000178894.51436.54","article-title":"Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.","volume":"65","author":"K\u00fcker","year":"2005","journal-title":"Neurology"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s002340000480","article-title":"Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings.","volume":"43","author":"Thurnher","year":"2001","journal-title":"Neuroradiology"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and treatment of primary CNS lymphoma.","volume":"9","author":"Korfel","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/hon.2087","article-title":"Primary lymphoma of the central nervous system--a diagnostic challenge.","volume":"32","author":"Deckert","year":"2014","journal-title":"Hematol Oncol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1470-7330-14-22","article-title":"MR imaging features of intracranial primary CNS lymphoma in immune competent patients.","volume":"14","author":"Mansour","year":"2014","journal-title":"Cancer Imaging"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"3606970","DOI":"10.1155\/2018\/3606970","article-title":"Primary CNS lymphomas: challenges in diagnosis and monitoring.","volume":"2018","author":"Chiavazza","year":"2018","journal-title":"Biomed Res Int"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood-2013-06-453084","article-title":"How I treat CNS lymphomas.","volume":"122","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1008201717089","article-title":"Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature.","volume":"8","author":"Reni","year":"1997","journal-title":"Ann Oncol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01053274","article-title":"Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.","volume":"19","author":"Hayakawa","year":"1994","journal-title":"J Neurooncol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejso.2004.10.002","article-title":"Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases.","volume":"31","author":"Bellinzona","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R52-20250504","first-page":"637","article-title":"Primary CNS lymphoma: the role of resection.","volume":"28","author":"Shankar","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"R53-20250504","first-page":"1601","article-title":"Primary central nervous system lymphoma.","volume":"23","author":"Han","year":"2017","journal-title":"Continuum (Minneap Minn)"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/neuonc\/nos159","article-title":"Surgery for primary CNS lymphoma? Challenging a paradigm.","volume":"14","author":"Weller","year":"2012","journal-title":"Neuro Oncol"},{"key":"R55-20250504","first-page":"632","article-title":"Surgery for primary central nervous system lymphoma: is it time for reevaluation?","volume":"28","author":"Bierman","year":"2014","journal-title":"Oncology (Williston Park)"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.14740\/jocmr2376w","article-title":"Primary diffuse large B-cell lymphoma of central nervous system: is still surgery an unorthodox treatment?","volume":"7","author":"Siasios","year":"2015","journal-title":"J Clin Med Res"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"e1436","DOI":"10.1016\/j.wneu.2019.02.252","article-title":"Surgical resection for primary central nervous system lymphoma: a Systematic Review.","volume":"126","author":"Labak","year":"2019","journal-title":"World Neurosurg"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-016-2358-8","article-title":"The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.","volume":"132","author":"Cloney","year":"2017","journal-title":"J Neurooncol"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11060-022-04200-7","article-title":"Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.","volume":"160","author":"Chojak","year":"2022","journal-title":"J Neurooncol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/02688697.2015.1071328","article-title":"The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.","volume":"30","author":"Jelicic","year":"2016","journal-title":"Br J Neurosurg"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/neuros\/nyy096","article-title":"Craniotomy and survival for primary central nervous system lymphoma.","volume":"84","author":"Rae","year":"2019","journal-title":"Neurosurgery"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3171\/2020.9.JNS201980","article-title":"Resection of primary central nervous system lymphoma: impact of patient selection on overall survival.","volume":"135","author":"Schellekes","year":"2021","journal-title":"J Neurosurg"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10143-018-0946-0","article-title":"The role of surgery in intracranial PCNSL.","volume":"41","author":"Jahr","year":"2018","journal-title":"Neurosurg Rev"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clineuro.2015.09.015","article-title":"Fluorescein sodium-guided surgery in cerebral lymphoma.","volume":"139","author":"Schebesch","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fonc.2020.00131","article-title":"Real-world impact of surgical excision on overall survival in primary central nervous system lymphoma.","volume":"10","author":"Deng","year":"2020","journal-title":"Front Oncol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/j.wneu.2020.04.049","article-title":"Clinical characteristics, surgical outcomes, and prognostic factors of intracranial primary central nervous system lymphoma.","volume":"139","author":"Ouyang","year":"2020","journal-title":"World Neurosurg"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00277-019-03821-9","article-title":"Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases.","volume":"99","author":"Yuan","year":"2020","journal-title":"Ann Hematol"},{"key":"R68-20250504","first-page":"52","article-title":"[Different treatment regimens for primary central nervous system lymphoma:based on SEER database].","volume":"59","author":"Yang","year":"2021","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11060-022-04081-w","article-title":"Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review.","volume":"159","author":"Ganau","year":"2022","journal-title":"J Neurooncol"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/02688697.2019.1710820","article-title":"Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.","volume":"34","author":"Kinslow","year":"2020","journal-title":"Br J Neurosurg"},{"key":"R71-20250504","first-page":"e15990","article-title":"A case report on primary central nervous system lymphoma in immunocompetent individual.","volume":"13","author":"Mandal","year":"2021","journal-title":"Cureus"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1200\/JCO.2015.64.8634","article-title":"Phase I and II Study of Induction Chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227.","volume":"34","author":"Glass","year":"2016","journal-title":"J Clin Oncol"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.critrevonc.2019.06.009","article-title":"Primary central nervous system lymphoma: novel precision therapies.","volume":"141","author":"Mondello","year":"2019","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:03:15Z","timestamp":1746345795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":73,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035954","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}